137 related articles for article (PubMed ID: 26964379)
1. The expression and significance of p53 protein and Ki-67 protein in pterygium.
Ljubojević V; Gajanin R; Amidzić L; Vujković Z
Vojnosanit Pregl; 2016 Jan; 73(1):16-20. PubMed ID: 26964379
[TBL] [Abstract][Full Text] [Related]
2. Expression of cell proliferation and apoptosis biomarkers in pterygia and normal conjunctiva.
Liang K; Jiang Z; Ding BQ; Cheng P; Huang DK; Tao LM
Mol Vis; 2011; 17():1687-93. PubMed ID: 21738398
[TBL] [Abstract][Full Text] [Related]
3. Bcl-2, p53, and Ki-67 expression in pterygium and normal conjunctiva and their relationship with pterygium recurrence.
Turan M; Turan G
Eur J Ophthalmol; 2020 Nov; 30(6):1232-1237. PubMed ID: 32703006
[TBL] [Abstract][Full Text] [Related]
4. Expression of p53 and Ki-67 proteins in patients with increasing severity and duration of pterygium.
Mahesh M; Mittal SK; Kishore S; Singh A; Gupta N; Rana R
Indian J Ophthalmol; 2021 Apr; 69(4):847-850. PubMed ID: 33727444
[TBL] [Abstract][Full Text] [Related]
5. Proliferative activity and p53 expression in primary and recurrent pterygia.
Chowers I; Pe'er J; Zamir E; Livni N; Ilsar M; Frucht-Pery J
Ophthalmology; 2001 May; 108(5):985-8. PubMed ID: 11320032
[TBL] [Abstract][Full Text] [Related]
6. Expression of CREB in primary pterygium and correlation with cyclin D1, ki-67, MMP7, p53, p63, Survivin and Vimentin.
Nubile M; Curcio C; Lanzini M; Calienno R; Iezzi M; Mastropasqua A; Di Nicola M; Mastropasqua L
Ophthalmic Res; 2013; 50(2):99-107. PubMed ID: 23838680
[TBL] [Abstract][Full Text] [Related]
7. The role of cyclin D1, BCL-2, p53 and Ki-67 in epithelial cells in the etiopathogenesis of pterygium.
Süren E; Nergiz D; Bilgin B; Çoban DT; Akgündüz Z; Sadullahoğlu C; Süren D
Indian J Pathol Microbiol; 2021; 64(2):238-242. PubMed ID: 33851614
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress in pterygium: relationship between p53 and 8-hydroxydeoxyguanosine.
Perra MT; Maxia C; Corbu A; Minerba L; Demurtas P; Colombari R; Murtas D; Bravo S; Piras F; Sirigu P
Mol Vis; 2006 Sep; 12():1136-42. PubMed ID: 17093398
[TBL] [Abstract][Full Text] [Related]
9. Abnormal expression of the p53 tumor suppressor gene in the conjunctiva of patients with pterygium.
Tan DT; Lim AS; Goh HS; Smith DR
Am J Ophthalmol; 1997 Mar; 123(3):404-5. PubMed ID: 9063255
[TBL] [Abstract][Full Text] [Related]
10. Deregulation of p53/survivin apoptotic markers correlated to PTEN expression in pterygium neoplastic cells.
Konstantopoulou K; Tsiambas E; Baliou E; Lazaris AC; Kavantzas N; Karameris A; Fotiades PP; Asproudis I; Ragos V; Vilaras G; Patsouris E; Konstantopoulou K; Tsiambas E; Baliou E; Lazaris AC; Kavantzas N; Karameris A; Fotiades PP; Asproudis I; Ragos V; Vilaras G; Patsouris E
J BUON; 2018; 23(3):826-831. PubMed ID: 30003758
[TBL] [Abstract][Full Text] [Related]
11. Study of the expression of CD30 in pterygia compared to healthy conjunctivas.
Garfias Y; Bautista-De Lucio VM; García C; Nava A; Villalvazo L; Jiménez-Martínez MC
Mol Vis; 2009 Oct; 15():2068-73. PubMed ID: 19862340
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of vascular endothelial growth factor (VEGF) and p53 expression in pterygium from Tunisian patients.
Khalfaoui T; Mkannez G; Colin D; Imen A; Zbiba W; Errais K; Anane R; Beltaief O; Zhioua R; Ben Hamida J; Lizard G; Ouertani-Meddeb A
Pathol Biol (Paris); 2011 Jun; 59(3):137-41. PubMed ID: 19481369
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical HLA-DR antigen expression with lymphocyte subsets and proliferative activity in pterygium.
Tsironi S; Ioachim E; Machera M; Aspiotis M; Agnantis N; Psillas K
In Vivo; 2002; 16(5):299-306. PubMed ID: 12494867
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of Hsp90 and Ki-67 in pterygium.
Sebastiá R; Ventura MP; Solari HP; Antecka E; Orellana ME; Burnier MN
Diagn Pathol; 2013 Feb; 8():32. PubMed ID: 23432803
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of p53 tumor suppressor gene in pterygia.
Weinstein O; Rosenthal G; Zirkin H; Monos T; Lifshitz T; Argov S
Eye (Lond); 2002 Sep; 16(5):619-21. PubMed ID: 12194078
[TBL] [Abstract][Full Text] [Related]
16. P53 gene mutation spectrum and the relationship between gene mutation and protein levels in pterygium.
Tsai YY; Cheng YW; Lee H; Tsai FJ; Tseng SH; Chang KC
Mol Vis; 2005 Jan; 11():50-5. PubMed ID: 15682042
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical study of p53, p21 and PCNA in pterygium.
Ueda Y; Kanazawa S; Kitaoka T; Dake Y; Ohira A; Ouertani AM; Amemiya T
Acta Histochem; 2001 Apr; 103(2):159-65. PubMed ID: 11368097
[TBL] [Abstract][Full Text] [Related]
18. Commentary: Expression of p53 and Ki-67 proteins in patients with increasing severity and duration of pterygium.
Arora R
Indian J Ophthalmol; 2021 Apr; 69(4):851. PubMed ID: 33727445
[No Abstract] [Full Text] [Related]
19. DNA damage in human pterygium: one-shot multiple targets.
Cimpean AM; Sava MP; Raica M
Mol Vis; 2013; 19():348-56. PubMed ID: 23401662
[TBL] [Abstract][Full Text] [Related]
20. Comment on: Expression of p53 and Ki-67 proteins in patients with increasing severity and duration of pterygium.
Dos Santos Martins TG
Indian J Ophthalmol; 2021 Oct; 69(10):2887. PubMed ID: 34571668
[No Abstract] [Full Text] [Related]
[Next] [New Search]
